Your browser doesn't support javascript.
loading
Core set of patient-reported outcomes for myelodysplastic syndromes: an EUMDS Delphi study involving patients and hematologists.
Stojkov, Igor; Conrads-Frank, Annette; Rochau, Ursula; Koinig, Karin A; Arvandi, Marjan; Puntscher, Sibylle; van Marrewijk, Corine; Fenaux, Pierre; Symeonidis, Argiris; Chermat, Fatiha; Garelius, Hege; Bowen, David; Mittelman, Moshe; Mora, Elvira; de Witte, Theo; Efficace, Fabio; Siebert, Uwe; Stauder, Reinhard.
Afiliação
  • Stojkov I; Institute of Public Health, Medical Decision Making, and Health Technology Assessment, Department of Public Health, Health Services Research and Health Technology Assessment, UMIT - University for Health Sciences, Medical Informatics, and Technology, Hall in Tirol, Austria.
  • Conrads-Frank A; Institute of Public Health, Medical Decision Making, and Health Technology Assessment, Department of Public Health, Health Services Research and Health Technology Assessment, UMIT - University for Health Sciences, Medical Informatics, and Technology, Hall in Tirol, Austria.
  • Rochau U; Institute of Public Health, Medical Decision Making, and Health Technology Assessment, Department of Public Health, Health Services Research and Health Technology Assessment, UMIT - University for Health Sciences, Medical Informatics, and Technology, Hall in Tirol, Austria.
  • Koinig KA; Department of Internal Medicine V (Hematology and Oncology), Innsbruck Medical University, Innsbruck, Austria.
  • Arvandi M; Institute of Public Health, Medical Decision Making, and Health Technology Assessment, Department of Public Health, Health Services Research and Health Technology Assessment, UMIT - University for Health Sciences, Medical Informatics, and Technology, Hall in Tirol, Austria.
  • Puntscher S; Institute of Public Health, Medical Decision Making, and Health Technology Assessment, Department of Public Health, Health Services Research and Health Technology Assessment, UMIT - University for Health Sciences, Medical Informatics, and Technology, Hall in Tirol, Austria.
  • van Marrewijk C; Department of Hematology, Radboud University Medical Center, Nijmegen, The Netherlands.
  • Fenaux P; Service d'Hématologie, Hôpital Saint-Louis, Assistance Publique des Hôpitaux de Paris (AP-HP) and Université Paris 7, Paris, France.
  • Symeonidis A; Department of Medicine, Division Hematology, University of Patras Medical School, Patras, Greece.
  • Chermat F; Groupe Francophone des Myélodysplasies (GFM), Paris, France.
  • Garelius H; Section of Hematology and Coagulation, Department of Medicine, Sahlgrenska University Hospital, Göteborg, Sweden.
  • Bowen D; St James's Institute of Oncology, Leeds Teaching Hospitals, Leeds, United Kingdom.
  • Mittelman M; Department of Medicine A, Tel Aviv Sourasky (Ichilov) Medical Center and Sackler Medical Faculty, Tel Aviv University, Tel Aviv, Israel.
  • Mora E; Hospital Universitario y Politécnico La Fe.
  • de Witte T; Instituto de Investigación Sanitaria La Fe, Valencia, Spain.
  • Efficace F; Department of Tumor Immunology, Nijmegen Center for Molecular Life Sciences, Radboud University Medical Center, Nijmegen, The Netherlands.
  • Siebert U; Health Outcomes Research Unit, Gruppo Italiano Malattie Ematologiche dell'Adulto (GIMEMA), Rome, Italy.
  • Stauder R; Institute of Public Health, Medical Decision Making, and Health Technology Assessment, Department of Public Health, Health Services Research and Health Technology Assessment, UMIT - University for Health Sciences, Medical Informatics, and Technology, Hall in Tirol, Austria.
Blood Adv ; 6(1): 1-12, 2022 01 11.
Article em En | MEDLINE | ID: mdl-34492684

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Qualidade de Vida / Síndromes Mielodisplásicas Tipo de estudo: Guideline / Observational_studies / Prognostic_studies / Qualitative_research Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Qualidade de Vida / Síndromes Mielodisplásicas Tipo de estudo: Guideline / Observational_studies / Prognostic_studies / Qualitative_research Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article